Antibody Depleted Human Complement

Pel-Freez Biologicals is the only commercially available, large volume supplier of IgG/IgM depleted human complement, which many of the world's largest vaccine companies and CROs have had great success with in their vaccine efficacy testing assays. Pel-Freez has recently scaled up a proprietary antibody depletion process which removes the problematic IgG and IgM antibodies that cause non-specific background killing in functional antibody assays like opsonophagocytic assays (OPAs) and serum bactericidal assays (SBAs) used for vaccine efficacy testing. Since 2017 we have developed a growing base of over 80 users including several Fortune 500 vaccine companies and CROS, and can produce lot sizes in excess of 4L at our ISO-certified facility. Our complement products are currently supporting several early and clinical stage pneumococcal, meningococcal, gonococcal vaccine programs and more. Many labs and companies waste valuable resources making their own in-house versions of this critical reagent in small batches. Let us save you time and money by making it for you in large volumes! More information about our complement products can be found on our On-Demand World Vaccine Congress 2020 Webinar, as well as on our website at: https://www.pelfreez-bio.com/ For ordering contact: biosales@pel-freez.com. For technical questions contact: techsupport@pel-freez.com For partnerships/collaborations contact: Dr. Brian Bonk, CEO at bbonk@pel-freez.com